Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  ZAI Lab Obtains Global Rights to Sanofi NSCLC Drug Candidate
  CFDA Requires Drugmakers to Verify Clinical Trial Data Filings
  Suzhou Connect Reports Positive Results for Trial of Autoimmune Drug
  China's Bloomage Forms Botox JV with Medytox of South Korea
  Boehringer Ingelheim Pays $730 Million for Hanmi Cancer Drug
  Shuwen Signs Companion Diagnostic Deal with Hengrui Medicine
  Yabao Pharma Starts Preclinical Studies on Sepsis Treatment
  Dr. Jun Wang, CEO of BGI, Steps Down
  Mitsui's Restructured Investment in Chi-Med Worth $84 Million
  3SBio Pays $85 Million to Acquire Zhejiang Washeng Pharma
 
Login

  

    
   
Partner Events

Bio Taiwan 2015
July 22-26, 2015
Taipei, Taiwan


BioPharm America™ 2015
September 15–17, 2015
Boston, USA

>> More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors